BAMS
INO icon

Bellevue Asset Management (Switzerland)’s Inovio Pharmaceuticals INO Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$1.78M Hold
22,083
– – 0.27% 90
2015
Q3 		$1.53M Buy
22,083
+5,416
+32% +$472K 0.25% 93
2015
Q2 		$1.63M Sell
16,667
-8,333
-33% -$890K 0.23% 96
2015
Q1 		$2.45M Buy
+25,000
New +$2.42M 0.34% 72

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s INO Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Inovio Pharmaceuticals (INO) position steady in Q4 2015 at 22,083 shares worth $1.78M. The position accounts for 0.27% of the portfolio, ranked #90.

Bellevue Asset Management (Switzerland) first reported a position in INO in Q1 2015 and has held it in 4 quarters since. The position peaked at $2.45M in Q1 2015. 123 funds tracked by Wall St. Rank hold INO as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 22,083 shares of Inovio Pharmaceuticals worth $1.78M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Inovio Pharmaceuticals share count unchanged in Q4 2015.
  • Inovio Pharmaceuticals made up 0.27% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #90 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Inovio Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Inovio Pharmaceuticals position peaked at $2.45M in Q1 2015.
  • 123 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.